Clinical Trials Update: Oct. 15, 2008
Memory Loss Melanoma Epilepsy
(HealthDay News) -- Here are the latest clinical trials, courtesy of CenterWatch:
If you know someone aged 50 to 90 who has been diagnosed with probable Alzheimer's disease or has memory problems that may be a sign of Alzheimer's, is not taking any Alzheimer's medication, and has a regular caregiver who is willing to attend all trial visits, that person may qualify for this study.
The research site is in Charlotte, N.C.
If you are 18 or older, have histologically confirmed metastatic (Stage IV) melanoma of cutaneous origin, an ECOG performance status of two or less, and a life expectancy of greater than 12 weeks, you may qualify for this study.
The research site is in Cincinnati, Ohio
If you are aged 16 to 75, have well-characterized focal epilepsy or epileptic syndrome, and are on a stable dose of one or two antiepileptic drugs, you may qualify for this study.
The research site is in Danville, Ind.
Copyright 2008 CenterWatch. All rights reserved.